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High-cell density culture is based on the chondrogenic differentiation of human mesenchymal stem cells (hMSCs), and because the high density of 
cell and reduced oxygen tension are effective in chondrogenic differentiation. In the present paper, there will be a review about the methods of 
chondrogenic differentiation of hMSCs that utilized in in vitro and in vivo chondrogenic differentiation of stem cells for treatment of osteoarthritis. 
There are three High-cell density culture systems; micromass, pellet culture, and alginate culture have been used to induce chondrogenic 
differentiation of hMSCs. Transplanted naive MSCs can cause problems such as heterogeneous populations. To overcome this problem, new 
strategies for inducing differentiation of MSCs are needed. One possibility is a cell culture system. Collagen II and aggrecan are critical protein in 
chondrogenic differentiation. In all different methods, real time RT-PCR analysis demonstrates that collagen II and aggrecan mRNA are up 
regulated while collagen X and collagen I mRNA are down regulated. So these three high-density cell culture systems have been approved for 
chondrogenic differentiation. On the other hand, In micromass method, the induced-cartilage tissues are larger, more homogenous and rich in 
cartilage specific collagen II, but collagen I, collagen X and hypertrophic chondrocyte features are markedly decreased compared to other culture 
system. Thus, the micromass culture system is the best tool for in vitro chondrogenic differentiation studies. 
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Introduction 
Osteoarthritis (OA) is a progressive, chronic and irreversible 
degenerative joint disease. Conventional osteoarthritis treatments 
often lead to significant complications, such as pain and limited 
activity. Transplantation of mesenchymal stem cells (MSCs) has 
several beneficial effects such as paracrine effects, anti-
inflammatory activity and immunomodulatory capacity. 
Transplantation of MSCs is also a suggested therapeutic approach 
for osteoarthritis treatment (1). 
Human MSCs are a promising alternative cell source for 
cartilage regeneration (2). Recently, MSCs have been applied for 
treatment of OA in clinical trials (3). MSCs are easily found in 
various tissues, including bone marrow, adipose tissue, spleen, 
synovial fluid, and lungs. These cells can differentiate into several 
cell types including adipocytes, chondrocytes, cardiomyocytes, 
endothelial cells and osteocytes (3, 4). Several studies suggested 
that therapeutic effects for treatment of OA were showed by 
transplantation of chondrogenic differentiated MSCs (5, 6). Thus, 
differentiation of MSCs into specific chondrogenic cells via their 
modulation for transplant has the potential for treatment of OA 
(Figure 1) (7). Although, MSCs have several beneficial effects, but 
there are three essential factors for considering in using 
undifferentiated cells (7): efficiency of direct differentiation of 
stem cells into specific cell types (8); the survival rate of 
transplanted cells (9); and host environment when the cells are 
transplanted because not all differentiated pathways have been 
discovered yet (10, 11).  
These approaches have limitations (7): undefined conditions 
leading to heterogeneous populations of cells (8), and  unexpected 
risk of virus-mediated genetic modifications (10). To overcome 
this issue, new strategies for inducing differentiation of MSCs are 
required. One possibility is a cell culture system. Several cell 
culture methods have been developed to create suitable 
environments for chondrogenic differentiation of MSCs, 
including monolayer culture, high-density cell culture 
(micromass culture, pellet culture, and alginate culture), hanging  
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Figure 1. Models of MSC differentiation. (A) In this theoretical model, MSCs in the bone marrow constitute a primitive stem cell population 
(multipotent MSCs), having the potential for self-renewal and proliferation as well as the capacity to differentiate into all connective tissue cell 
types, when exposed to a defined environment. (B) An alternative model illustrating MSCs in vivo as a population of cells with different 
differentiation potentials (i.e., quadra-, tri-, bi- and uni-potential). During in vitro culture, this heterogeneous mixture of stem and committed 
progenitor cells is limited in his multilineage differentiation [7]. Permissions obtained from the publisher 
 
drop and biomaterial-based scaffold culture. In the present 
review, high cell-density culture methods in the chondrogenic 
differentiation of human MSCs will be discussed. 
One of these methods is alginate culture. Alginate beads 
are considered as a classic method for culturing 
chondrocytes. The original method of chondrocyte culture in 
the alginate beads was developed in the late eighties by Guo 
et al. (12) and was then employed and improved by other 
researchers. Chondrocytes are released from cartilage matrix. 
Beads are easy to handle and biological applications are 
compatible with this model of culture (13). Culture in 
alginate beads is also useful to re-differentiate chondrocytes 
that have dedifferentiated because of expansion in 
bidimensional culture (14).  
Morphology of the three-dimensional (3D) constructs 
varies depending on whether the culture is a solid suspension 
such as alginate or agarose, where the MSCs form small groups 
and clusters interspersed throughout the support, or a the cells 
are condensed such as various sized pellet cultures that cells are 
more tightly packed in a tissue-like structure (Figure 2). 
Pellet culture method is a standard method for the 
chondrogenesis of MSCs. This system provides a three-
dimensional environment that allows cell–cell interactions 
similar to those observed in pre-cartilage condensations 
found during embryonic development. MSCs are capable of 
chondrogenic differentiation in pellet culture using serum-
free medium containing glucocorticoids and transforming 
growth factor (TGFβ1) family (15). Therefore, pellet culture 
is widely used to evaluate the chondrogenic potential of 
MSCs and to study the signal pathways involved in 
chondrogenesis (16). Micromass culture system, first used to 
study endochondral skeletal development with embryonic 
chicken limb bud MSCs (17), has recently been applied to 
induce chondrogenesis in MSCs (18). Several studies have 
utilized micromass method for cartilage differentiation; 
because this method was designed based on generating 
cartilage from MSCs in the embryonic period. In micromass 
culture, transforming growth factor β1 (TGFβ1) treatment 
significantly increases the synthesis of the cartilage 
phenotypic markers (SOX9, COL2A1, and ACAN) and down-
regulate the catabolic (MMP13 and ADAMTS5) gene 
products in extracellular matrix (19). 
 
Applied Methodology 
Bone marrow harvest, cell isolation and expansion 
In most studies, bone marrow samples were obtained from 
healthy volunteers and MSCs were isolated and purified by 
density gradient centrifugation combined with an attachment 
culture method (20, 21). Briefly, the bone marrow samples 
(8–10 ml) are diluted with 20 ml phosphate-buffered saline 
(PBS), then the cells fractionated on a Lymphoprep density 
gradient by centrifugation at 500g for 20 minutes. The 
interfacial mononuclear cells are collected and washed with 
low-glucose. 
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Figure 2. Photomicrographs of MSC 3D cultures collected at 28 days and stained with hematoxylin and eosin. (A, B) FA, (C, D) alginate, (E, F) 
2.5 · 105 pellet, (G, H) 5 · 105 pellet, and (I, J) agarose. 200 · magnification. Images were taken at 100 · magnification. Black box represents area for 
magnified image adjacent to original. Scale bar = 200 mm [14]. Permissions obtained from the publisher 
 
Dulbecco’s modified Eagle medium (LG-DMEM) 
supplemented with 10% (v/v) FBS. The MSC primary cultures 
are seeded at a density of 106/cm2 in LG-DMEM with 10% FBS 
in 25 cm2 flasks. The cells are incubated at 37°C under 5% CO2.  
Non-adherent cells are removed from the flasks after 48 h by 
changing the medium. Thereafter, the medium is changed 
every 3 days. Typically, cultures reach 80–90% confluency in 
day 14. In this stage, cells are trypsinized from the culture 
dishes using 0.25% trypsin containing 0.53 mM EDTA, 
counted and plated again. Cells from the 3rd passage are 
usually used for experiments. In the first passage (P0), cells 
show the typical fibroblast-like morphology of primary MSCs. 
During culture expansion up to P3, cells are slightly flattened 
but still have fibroblast-like morphology. In P3, MSC 
verification is performed by flow cytometry analysis from 
surface marker profile. As expected, MSC are uniformly positive 
for CD44, CD73, CD90, CD105, and CD166 and negative for the 
hematopoietic markers CD14, CD34, and CD45. Several studies 
have shown the multilineage differentiation potential of MSCs 
while here we are only focusing on their chondrogenic 
differentiation potential (Figure 3). 
Chondrogenic differentiation of MScs by High density 
cell culture methods  
Alginate culture 
In alginate culture method MSCs or chondrocytes are released from 
cartilage by collagenase/dispase digestion. Then, they are mixed 
with a solution of 1.25% of alginic acid to obtain homogenous 
suspension. The suspension is drawn into a syringe and push gently 
through a needle, so that drops fall into a solution of calcium 
chloride. Beads form instantaneously and further polymerize after 
5 min in the calcium chloride solution. MSCs or chondrocytes from 
any species, including human OA chondrocytes, can be cultured by 
using this technique (22). Encapsulated chondrocytes are still able 
to respond to growth factors and cytokines (23). Under these 
conditions, chondrocytes maintain a high degree of differentiation. 
Beads can be dissolved by chelation of calcium with EDTA. Almost 
all molecular and biochemical techniques, as well as a number of 
biological assays, are compatible with the culture of chondrocytes 
in alginate (22, 23). 
Alginate beads are 3D scaffolds that closely resemble the 
cartilage matrix (24). In many studies, changings in chondrogenic 
genes were characterized and developed a stage for in vitro 
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Figure 3. (A) During isolation, human bone marrow mesenchymal stem cells (MSCs) appear as single cells in passage 0 (P0), (B) then they 
showed uniform growth and fibroblast like morphology in P3. (C) On FACS analysis the cells were positive for typical MSC antigens like CD166, 
CD105, CD90, CD73, and CD44, while negative for hematopoietic lineage-specific antigens like CD45, CD34, and CD14. Bar: 500 lm. [21]. 
Permissions obtained from the publisher 
 
chondrogenic differentiation of human MSCs in 3D alginate gels. 
A time-dependent accumulation of glycosaminoglycans, 
aggrecan, and type II collagen is observed in chondrogenic but not 
in basal constructs over 24 days. In qRT-PCR, a largely 
characteristic pattern of chondrogenic markers is demonstrated, 
that provide a basis for staging the cellular phenotype into four 
stages. Stage I (days 0–6) is defined by collagen types I and VI, Sox 
4, and BMP-2 showing peak expression levels. In stage II (days 6–
12), gene expression of cartilage oligomeric matrix protein, 
HAPLN1, collagen type XI, and Sox 9 reaches the peak levels, 
while gene expression of matrilin 3, Ihh, Homeobox 7, 
chondroadherin, and WNT 11 is peaked at stage III (days 12–18). 
Finally, cells in stage IV (days 18–24) demonstrate peak levels of 
aggrecan; collagen IX, II, and X; osteocalcin; fibromodulin; 
PTHrP; and alkaline phosphatase. Gene profiles at stages III and 
IV are analogous to those in juvenile articular and adult nucleus 
pulposus chondrocytes. These data provide comprehensive 
insights on chondrogenesis of human MSCs in 3D gels (25).  
In another study, the differentiation of human MSCs was 
considered into chondrocytes under defined conditions in 3D 
alginate gels in vitro as one of the high-cell density culture, and 
also, that temporal change in gene expression in this system 
largely paralleled the spatial pattern of in vivo cartilage maturation 
in many important aspects (25).  
Specifically, the early gene expression profiles are similar to 
that in precursor cells, with the cells showing progressive increase 
in markers of chondroprogenitors followed by that of mature 
chondrocytes and then by hypertrophic chondrocytes defined by 
robust upregulation of collagen type X, alkaline phosphatase, and 
osteocalcin (25, 26).  
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These stage-specific gene profiles show similarities at the 
earlier time point to those in fibroblast-like annulus fibrosus 
cells and in the later stages to juvenile chondrocytes and adult 
nucleus pulposus chondrocytic cells. The findings also provide 
insights into the stage-specific gene profiles of human MSCs 
undergoing chondrogenic differentiation in vitro that may be 
a useful to study differences in human MSC responses to 
various stimuli, such as mechanical load (27).  
Biomaterial-based scaffolds extensively have been used in 
the field of tissue engineering. They may be better than 
micromass culture systems and pellet culture systems in the 
control of diffusion of nutrients and oxygen tension, because, 
scaffold properties such as material biocompatibility, porosity, 
mechanical strength, and incorporation of signaling molecules 
can be optimized to address various physiological requirements 
of an engineered cartilage tissue (28). Additionally, biomaterial-
based scaffold cultures can provide a larger size cartilage tissue 
with stronger mechanical properties comparing to micromass 
culture systems and pellet culture systems (28). 
Pellet culture system  
In this method MSCs are centrifuged (150 g, 5 min) in a 15-mL 
polypropylene tube to form a pellet for chondrogenic 
differentiation in the high-cell density pellet cultures. The pellets 
are treated for 28 days with defined serum-free chondrogenic 
medium, which consist of DMEM (4.5 g/L glucose), ITS + 1 
supplement, 100 mM dexamethasone, 0.17 mM L-ascorbic acid-
2-phosphate, 1mM sodium pyruvate, 0.35mM L-prolin and 10 
ng/mL TGFβ3. Control pellets are cultured in the same medium 
without TGFβ3. The medium is changed every 3 days and pellets 
are harvested on days 7, 14 and 21 (21).  
MSC are stimulated with TGFβ3 in the standard pellet 
culture assay for chondrogenic differentiation. After initial 
centrifugation in 15 mL polypropylene tubes, MSCs settle and 
form loose and spherical pellets. During the first week, pellets 
start to increase in size and have a thinner central zone as 
compared to a thicker circumferential border. After 28 days, 
pellets are converted into firm, mechanically strong cultures. At 
that point, alcian blue staining of cartilage proteoglycans and 
antibody staining of cartilage-specific collagen type II reveal the 
formation of a cartilaginous extracellular matrix (ECM). Both 
alcian blue and collagen type II staining are negative in 
unstimulated pellet cultures. On the gene expression level, 
chondrogenesis is measured by significantly increased 
expression of the cartilage marker genes SOX9 and COL2A1 
from day 0 to day 28. Both genes are also much more expressed 
in stimulated cultures than in unstimulated cultures (21). 
The 3D high-cell density pellet culture is the standard assay 
for chondrogenesis in vitro. Spherical MSCs pellet is 
chondrogenically induced by the addition of the standard 
stimulus, TGFβ, leading to a firm, spherical MSC pellet 
resembling hyaline cartilage and consisting of differentiated 
MSC and their ECM. The ECM mostly consists of different 
proteoglycans and collagens, which are usually cross-linked 
and provide a protective cage in which the TGFβ-stimulated 
MSCs are entrapped. So, the isolation of these cells from their 
ECM is a challenging task, but is the prerequisite to deliver 
viable, chondrogenically differentiated MSCs (21).  
In one study, Mujib Ullah and et al. designed a protocol for 
isolation of chondrogenic differentiated human MSCs from 
high-cell density pellet cultures. First, MSC were stimulated with 
TGFβ3 for 28 days to generate high-density pellet cultures. The 
chondrogenic nature of these pellets was verified by 
histochemical examination of cartilage proteoglycan, antibody 
staining of cartilage collagen type II, and qPCR of COL2A1 and 
SOX9. Then, to start pellet digestion, trypsin was applied 
because it is broadly accepted as the enzyme for release of cells 
from culture surfaces and diverse native tissues. Initially trypsin 
did not release any cells from intact whole pellets, and very few 
cells were released from small pieces of knife-scraped pellets. In 
line with these results, trypsin was previously found to be 
insufficient to isolate chondrocytes from cartilage. Since 
cartilage and chondrogenic pellet cultures contain a huge 
amount of collagen, collagenases are important digestion 
enzymes. Some studies had used a mixture of collagenase II and 
collagenase P to isolate chondrocytes from normal and 
osteoarthritic cartilage. Therefore, comparison of these two 
enzymes alone or in combination demonstrated a mixture of 
300U of collagenase II and 20U of collagenase P optimum at 90 
and 120 min of incubation for maximum release of viable cells. 
But most cells, either died in subsequent culturing or otherwise 
showed a low proliferation rate. However, the viable, 
chondrogenic cells showed different morphologies. One reason 
may be a non-uniform nutrient supply to single cells or cell 
aggregates inside high-density pellet cultures. It also seems 
possible that the chondrogenic capacity of the primary MSCs 
varied. based on cartilage proteoglycan, collagen type II 
expression and genes play a substantial role in providing 
purified chondrogenic cells and ECM for future regenerative 
application (21). 
In this context the high-cell density pellet culture represents 
a model system to provide a large amount of chondrogenic 
MSCs, especially when such cells should be applied as a 
suspension for regenerative application (15). However, inside 
the intact pellet culture, the cells and their secreted ECM 
components enclose and fix each other, hindering the release of 
chondrogenic MSCs (29, 30). This emphasizes the need for a 
successful protocol to isolate cells from pellets, despite an array 
of published protocols for chondrocyte isolation from native 
cartilage. Unfortunately, such protocols are not applicable to 
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isolating viable cells from pellets, and we believe that appropriate 
pellet digestion represented the key step to achieve this protocol, 
but to our knowledge, no successful procedure for the isolation 
of such cells from pellets has been published (31, 32). 
Micromass culture system 
In typical cell therapy strategies, the implanted cells are 
terminally differentiated cells that are intrinsic to the healing 
site. Therefore, one important step in preparing MSCs for 
clinical use is providing the condition in which the cells can 
differentiate into mature cartilage before being implanted. This 
will guarantee the transplantation of only chondrocytes and 
therefore avoid the undesirable bone formation in the case of 
undifferentiated cell implantation. The micromass culture 
system is the routine in vitro preparation for MSCs to undergo 
cartilage differentiation; in this system, the cells are cultivated as 
a condensed aggregate. Manning et al. first described it for 
cultivation of human articular chondrocyte (33). Johnstone et al. 
later reported the differentiation of MSCs into cartilage in this 
system (34). Numerous investigations have already shown the 
effectiveness of micromass culture system for cartilage 
differentiation of MSCs from human and a variety of species (35, 
36). In this technique, MSCs are first condensed into a pellet and 
then exposed to chondrogenic medium for three weeks. Using 
micromass culture system, MSCs could easily differentiate into 
cartilage with the characteristic metachromatic matrix 
accumulated among the cells. Morphologic events have already 
been investigated during in vitro chondrogenesis using the 
micromass culture system (37), but the exact final structural 
differentiation of MSCs into cartilage tissue, the subject of the 
present study, has not yet been reported. Such investigations 
would help to understand the potentials of micromass culture 
system in producing fully-matured cartilage tissue that is 
suitable for transplantation purposes.  
A micromass culture system of primary immature 
chondrocytes for functional analysis of soluble factors involved 
in the maturation step of cartilage was developed. For 
micromass cultures, the protocol was described by De Bari et 
al. Briefly, confluent monolayer cultures of chondrocyte cell 
lines are released by trypsin-EDTA, are tested for viability by 
trypan blue exclusion, and re-suspended in growth medium at 
a density of 2.5 × 107 viable cells/mL. Micromasses are obtained 
by pipetting 20 μL of cell suspension into individual wells of 
24-well plates. Following a 3-h attachment period without 
medium, the growth medium is gently added and cultures left 
resting for a further 24 h. The medium is then changed to 
serum-free and phenol red-free medium (Gibco BRL) for 24 h. 
Differentiation is promoted by serum starvation and ITS 
supplementation. On day 3 of the culture, fresh differentiation 
medium is added. After 48 h, some of the micromasses are 
harvested for Alcian blue matrix staining and others for qRT-
PCR gene expression analysis of gene markers for 
chondrocytes: type II collagen alpha-1 (COL2A1), aggrecan 
(ACAN), sex determining region (SRY)-box 9 (SOX9), matrix 
metalloproteinase-1 and -13 (MMP1, MMP13), and a 
disintegrin and metalloproteinase with a thrombospondin type 
1 motif 5 (ADAMTS5) (19).  
Since the introduction of micromass culture system by 
Johnston et al., scientists have utilized the system for different 
purposes. Some researchers used it to study the role of 
macromolecules such as bone morphogenetic protein-6 
(BMP6) family in promoting chondrogenic differentiation (36, 
38). Others have cultivated MSCs in micromass culture system 
to investigate molecular events during in vitro chondrogenesis 
that resulte in defining the expression pattern of cartilage 
specific molecules such as collagen II, X, and aggrecan (18, 27, 
28). Still other scientists have used this culture system to 
evaluate the chondrogenic potential of the cells isolated by 
different methods (39, 40). 
Ichinso et al. (2005) cultured human MSCs in a micromass 
culture system for 21 days in order to investigate the 
morphologic changes during in vitro chondrogenesis. They 
concluded that in vitro chondrogenesis is very similar to that 
of in vivo (37).  
Differentiation Analysis 
Real-time PCR 
In reverse transcription and real-time PCR analysis total RNA 
is isolated from pellets and micromasses using Trizol_ reagent 
according to the manufacturer’s protocol. Total RNA (1 µg) is 
then converted to cDNA. All real-time qPCR are performed on 
a real-time PCR System in 20 µl reaction volumes containing 
10 µl of SYBR Green I Master Mix, 0.6 µl 10 mM sense or 
antisense primer and 7.8 µl RNAse free water. The expressions 
of the following genes are examined: collagen type I 
(COL1A1), collagen type II (COL2A1), collagen type X 
(COL10A1), aggrecan and SOX-9. Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) is used as a housekeeping 
gene. Primer sequences are listed in Table 1. The PCR reaction 
is performed for 1 min at 95°C, follow by 39 amplification 
cycles (15 s at 95°C, 15 s at 60°C, 20 s at 72°C). After the last 
cycle, a melt-curve is generated. Each PCR is processed in 
triplicate. The Ct value of GAPDH is subtracted from the Ct 
value of the interest gene (ΔCT). The average ΔCT value of the 
triplicates is taken. MSCs culture in the pellet culture system is 
used as controls (ΔΔCT). Relative expression levels for each 
primer set are expressed as fold changes by the 2- ΔΔCT method 
(41, 42). 
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Table 1. Primers used in real time RT-PCR for chondrogenic differentiation 
Gene (accession no.) Primer sequence Product size (in base pairs) 

























Histology and immunohistochemistry 
At specified times, cell aggregates (pellets and micromasses) are 
fixed in 4% paraformaldehyde for 3 h, and then dehydrated with 
ethanol, wash with xylene and embeded in paraffin. Sections at 
5 µM are cut and mounted on glass slides. Toluidine blue 
staining for proteoglycan and immunohistochemistry for 
collagen types I, II and X are performed. For toluidine blue 
staining, sections are deparaffinized with xylene and ethanol, 
and 1% toluidine blue sodium borate is applied for 30 min and 
wash with distilled water. For immunohistochemistry, the 
streptavidin–peroxidase-conjugated method is used. After 
deparaffinization, tissue sections are briefly treated with pepsin 
at 37°C for 10 min. The sections are then incubated for 10 min 
with a peroxidase-blocking solution and reacted with the 
appropriate primary antibodies (mouse anti-human collagen 
type II monoclonal antibody, mouse anti-human collagen type I 
monoclonal antibody, mouse monoclonal anti-human collagen 
type X antibody) diluted in PBS containing 0.2% Triton X-100 
and the appropriate 2% normal serum overnight at 4°C. After 
rinsing with PBS, the slides are incubated for 10 min at room 
temperature with biotin-conjugated secondary antibodies, 
follow by incubation with streptavidin conjugated peroxidase 
working solution for 10 min. Subsequently, sections are stained 
for 10 min with 3, 30-diaminobenzidine tetrahydrochloride 
(DAB), counter stained with Mayer’s hematoxylin, dehydrated 
and mounted. Negative controls are prepared by substituting 
PBS for the primary antibody (41, 42). 
Transmission electron microscopy (TEM) 
Day 14 cell aggregates are fixed with 2.5% glutaraldehyde in 0.1 
M PBS for 2 h. The aggregates are then washed overnight at 4°C 
in the same buffer and post-fixed with 1% OsO4 buffer with 0.1 
MPBS for 2 h. Aggregates are then dehydrated in a graded series 
of ethanol and embeded in epoxy resin. Ultrathin sections are 
double-stained with uranyl acetate and lead citrate, followed by 
examination with a transmission electron microscope (41, 42). 
Discussion 
The 3D high-cell density culture is considered as a standard culture 
model for its entrapped chondrogenically differentiated cells. High-
cell density culture environment is pivotal for the chondrogenic 
differentiation of hMSCs. High-cell density pellet culture systems 
formed by centrifugation are widely used to evaluate the 
chondrogenic capacity of MSCs and to study the signal pathways 
involved in chondrogenesis. The presented literature demonstrated 
that the micromass culture system, another high-cell density culture 
system formed by high-cell density suspension, is superior to the 
other high-cell density culture. In the micromass cultures, the 
induced cartilage tissues are more homogenous and rich in 
cartilage-specific collagen II, but comparing to the pellet cultures 
and alginate cultures there are markedly decreased fibrocartilage-
like features, collagen I, hypertrophic chondrocyte features, 
collagen X, indicating that the micromass culture system is a 
promising tool for in vitro chondrogenic studies. 
Bone marrow-derived MSCs are heterogeneous with 
different mesenchymal lineage potentials (20), but the induced-
cartilage is more homogeneous in micromass cultures than that 
in other high-cell density cultures. We speculate that this 
phenomenon is due, in part, to the culture conditions. Although, 
high-cell density and low oxygen tension seem to enhance MSC 
chondrogenesis (43, 44), the optimal cell density and oxygen 
tension remain unclear (45, 46). Micromass culture, is formed 
by high-cell density suspensions, may do better in nutrient 
supplementation. Pellet culture is prepared by centrifugation, 
and may create a low oxygen tension environment with 
extremely high-cell density, resulting in poor nutrient diffusion 
and eventually MSC apoptosis in the central region. Thus, there 
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should be a balance between high cell density and the diffusion 
of nutrients in the process of MSC chondrogenesis. Micromass 
cultures may provide an optimal cell density environment 
allowing cell-cell contact and diffusion of nutrients. 
On the other hand, it is more convenient to use micromass 
cultures than biomaterial-based scaffold cultures (alginate 
culture method) to investigate the molecular mechanisms 
regulating chondrogenesis, such as the relationship between 
various signaling molecules and MSC chondrogenesis, thus 
validating the importance of this model. 
The distinct difference between the micromass and other 
high density cell cultures is the efficiency of MSC chondrogenic 
differentiation. The same initial number of MSCs is induced into 
a much larger cartilaginous tissue in the micromass cultures. 
Histochemical results demonstrate a greater deposition of 
cartilage specific extracellular matrix, proteoglycans and 
collagen II in the micromass cultures. Furthermore, COL2A1 
and aggrecan mRNA levels exhibit a 1.97 and 2.12-fold increase, 
respectively, in micromass cultures comparing to that in other 
culture systems. However, stronger matrix production in 
micromass cultures is not accompanied by the up-regulation of 
SOX-9, which is an important transcription factor involved in 
chondrogenesis (47). It is likely that the expression of SOX-9 at 
low levels is already sufficient to support matrix production, 
suggesting that other factors may contribute to the higher 
efficiency of chondrogenesis in micromass cultures. However, a 
3D culture environment alone cannot maintain prolong 
chondrogenesis. Previous studies have reported the expression 
of hypertrophic-associated genes, such as collagen X, and 
fibrocartilage-like features as well as collagen I in pellet cultures 
(19, 48). In another study, expressions of collagen X and collagen 
I were significantly down-regulated in micromass cultures 
compared to that in pellet cultures, suggesting that the induced-
cartilage in micromass cultures is more similar to hyaline 
cartilage. So the micromass culture system is more efficient than 
the standard pellet culture system and alginate culture in MSC 
chondrogenesis. Furthermore, the expressions of collagen X and 
collagen Iare down-regulate in MSCs differentiated in the 
micromass cultures indicating that the induced-cartilage is more 
similar to hyaline cartilage. 
Conclusion 
In this study, we considered a comparative review of 
chondrogenic differentiation of hMSCs cultured in the 
micromass culture, pellet culture and alginate culture. The 
literature suggested that the micromass culture system is 
superior to the pellet culture system and alginate culture. It 
indicates that the micromass culture system is a superior 
approach to study the chondrogenic potential of human MSCs. 
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